Armstrong, Fleming & Moore »

AstraZeneca shares owned by Armstrong, Fleming & Moore

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Armstrong, Fleming & Moore from 13F filings

Historical chart of Armstrong, Fleming & Moore investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Armstrong, Fleming & Moore consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Armstrong, Fleming & Moore

Quarter filed Position value Share count Share price at filing
2025-09-30 $212k 2.8k 76.72
2024-09-30 $214k 2.7k 77.92
2024-06-30 $213k 2.7k 77.99

More positions owned by Armstrong, Fleming & Moore

T Rowe Price Etf Price Blue Chip (TCHP)
Apple (AAPL)
Capital Group Intl Focus Eqt Shs Creation Uni (CGXU)
Cava Group Ord (CAVA)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Capital Group Dividend Value Shs Creation Uni (CGDV)
NVIDIA Corporation (NVDA)
Palantir Technologies Cl A (PLTR)
Costco Wholesale Corporation (COST)
Marriott Intl Cl A (MAR)
Science App Int'l (SAIC)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Capital Group New Geography SHS (CGNG)
Tesla Motors (TSLA)

View all positions for Armstrong, Fleming & Moore

Top funds holding AstraZeneca

PRIMECAP Management Company
Wellington Management Company
Capital Research and Management Company - Division 3
FMR
Fisher Investments
Franklin Resources
Sanders Capital
Goldman Sachs Group
Morgan Stanley
Atlantic Trust
Dimensional Fund Advisors
Holocene Advisors
BlackRock
Ameriprise Financial
Robeco Investment Management

View all funds holding AstraZeneca